Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

计划入组 248 人 · 首次发布于 2016 年 6 月 2 日

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

计划入组 36 人 · 首次发布于 2023 年 2 月 13 日

Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

计划入组 36 人 · 首次发布于 2024 年 2 月 20 日

rVSV vector vaccine (Emergent BioSolutions/Coalition for Epidemic Preparedness Innovations)

rVSV-delta-G-SUDV-GPC vaccine

pDNA/rVSV vector vaccine (Auro vaccines)

AIM VACCINE

China

Finlay Vaccine Institute

Path Vaccine Solutions

United States

The Ebola Vaccine That Sat on the Shelf for 15 Years: Why a Promising Bundibugyo Candidate Is Only Now Racing Toward Human Trials

WHO and Africa CDC Prioritize Experimental Ebola Treatments and Vaccines for Bundibugyo Strain Amid DRC Outbreak

IAVI Initiates First-in-Human Trial of Single-Dose Marburg Virus Vaccine Candidate